Top Tech Stocks For 2018

Inspire Medical Systems (INSP) has gone public and its shares have seen a great opening day return. The medical device company has great prospects as shares jumped 50% on their opening day. The still limited valuation and the potential of its therapy make that I am still happy to buy a few shares, which I regard as a long-term call option on the potential success of the business.

Minimally Invasive Solutions

Inspire Medical is a medical tech company which focuses on development and commercialisation of minimally invasive solutions for patients which are diagnosed with obstructive sleep apnea. The company has developed its proprietary Inspire system, as the company claims that this is the only FDA approved neurostimulation technology which offers an effective treatment for obstructive sleep apnea.

The Inspire therapy essentially monitors breathing patterns and delivers nerve stimulation to maintain open airways. The company has been marketing this therapy in certain European countries from 2011 onward, as FDA approval was granted in April of 2014. Note that patients must have moderate to severe sleep apnea and must not have a complete concentric collapse of the airway before being considered for treatment. Patients, furthermore, need to be 22 years of age, or older, and not be tolerant to airway pressure treatments.

Top Tech Stocks For 2018: Leggett & Platt, Incorporated(LEG)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Leggett & Platt (NYSE: LEG) and Hooker Furniture (NASDAQ:HOFT) are both consumer discretionary companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, risk and profitability.

Top Tech Stocks For 2018: China Eastern Airlines Corporation Ltd.(CEA)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Sanmina Corp (NASDAQ: SANM) shares rose 15.2 percent to $31.90 in pre-market trading as the company reported stronger-than-expected earnings for its second quarter on Monday.
    Cadence Design Systems, Inc. (NASDAQ: CDNS) rose 12.4 percent to $41.30 in pre-market trading after the company posted upbeat Q1 results and issued a strong Q2 forecast.
    Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) rose 10.8 percent to $8.75 in pre-market trading.
    Mitel Networks Corporation (NASDAQ: MITL) rose 8.8 percent to $11.05 in pre-market trading after the company agreed to be acquired by affiliates of Searchlight Capital Partners for $2.0 billion.
    Galectin Therapeutics, Inc. (NASDAQ: GALT) rose 7.3 percent to $3.70 in pre-market trading.
    Riot Blockchain, Inc. (NASDAQ: RIOT) shares rose 6.9 percent to $7.00 in pre-market trading after declining 1.50 percent on Monday.
    Hallmark Financial Services, Inc. (NASDAQ: HALL) rose 6.5 percent to $10.68 in pre-market trading.
    Boot Barn Holdings, Inc. (NYSE: BOOT) rose 5.2 percent to $20.40 in pre-market trading after gaining 4.53 percent on Monday.
    New Oriental Education & Technology Group Inc. (NYSE: EDU) rose 5 percent to $91.16 in pre-market trading after reporting Q3 results.
    Shire plc (NASDAQ: SHPG) rose 5 percent to $167.98 in pre-market trading after Bloomberg reported that Takeda is nearing a preliminary agreement to acquire Shire after sweetened bid.
    Outfront Media Inc. (NYSE: OUT) shares rose 5 percent to $19.00 in pre-market trading.
    Geron Corporation (NASDAQ: GERN) rose 4.3 percent to $4.18 in pre-market trading after gaining 5.80 percent on Monday.
    SAP SE (NYSE: SAP) rose 3.7 percent to $109.80 in pre-market trading after the company posted strong quarterly results and raised its outlook for the year.
    Golden Ocean Group Limited (NASDAQ: GOGL) shares rose 3.7 percent to $8.70 in pre-market trading after gaining 1.45 percent on Monday.
    Deutsche Bank Aktiengesellschaft (NYSE: D

Top Tech Stocks For 2018: Tennessee Valley Authority(TVE)

Advisors’ Opinion:

  • [By Shane Hupp]

    Tamarack-Valley-Energy (CVE:TVE) had its price objective raised by equities research analysts at BMO Capital Markets from C$3.75 to C$4.50 in a research note issued on Friday. BMO Capital Markets’ target price points to a potential downside of 82.02% from the stock’s current price.